 Group C: individuals with unique or under-recognized features of NF1 of any age, gender or ethnicity and must have a correct clinical diagnosis of NF1 NIH Consensus Development Conference 1988. all Group C participants enrolling in the study identify a physician who will be responsible for follow-up care so this can be arranged if needed at the conclusion of the evaluation at NIH. 